TY - JOUR
T1 - IBD - Genes, bacteria and new therapeutic strategies
AU - Colombel, Jean Frederic
PY - 2014/11/5
Y1 - 2014/11/5
N2 - IBD is known to be associated with an abnormal response to an unbalanced gut microbiota in genetically predisposed individuals. The therapeutic goal now is to control progression of the disease. Given the heterogeneity of IBD, the two universes of basic and clinical science must work in parallel to realize the hope of personalized therapy.
AB - IBD is known to be associated with an abnormal response to an unbalanced gut microbiota in genetically predisposed individuals. The therapeutic goal now is to control progression of the disease. Given the heterogeneity of IBD, the two universes of basic and clinical science must work in parallel to realize the hope of personalized therapy.
UR - http://www.scopus.com/inward/record.url?scp=84908491221&partnerID=8YFLogxK
U2 - 10.1038/nrgastro.2014.170
DO - 10.1038/nrgastro.2014.170
M3 - Review article
C2 - 25311475
AN - SCOPUS:84908491221
SN - 1759-5045
VL - 11
SP - 652
EP - 654
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
IS - 11
ER -